We are live on ! Find out more
SOW

State of Wyoming Portfolio holdings

AUM $989M
1-Year Est. Return 52.24%
This Fund
S&P 500
This Quarter Est. Return
+0.64%
1 Year Est. Return
+52.24%
3 Year Est. Return
+130.83%
5 Year Est. Return
+163.43%
10 Year Est. Return
AUM
$156M
AUM Growth
-$3.16M
Cap. Flow
-$1.64M
Cap. Flow %
-1.06%
Top 10 Hldgs %
18.99%
Holding
1,392
New
197
Increased
444
Reduced
602
Closed
144

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.6M
2
GLD icon
SPDR Gold Trust
GLD
+$1.11M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$550K
4
JPM icon
JPMorgan Chase
JPM
+$487K
5
AMZN icon
Amazon
AMZN
+$483K

Sector Composition

Rank Sector Weight
1 Technology 25.75%
2 Healthcare 16.1%
3 Consumer Discretionary 13.24%
4 Financials 12.71%
5 Communication Services 10.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QTEK
1101
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
$5K ﹤0.01%
470
+351
+295% +$3.47K
WPCB
1102
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
$5K ﹤0.01%
+554
New +$5.41K
GBT
1103
DELISTED
Global Blood Therapeutics, Inc.
GBT
$5K ﹤0.01%
182
-88
-33% -$2.59K
IRCP
1104
DELISTED
IRSA Propiedades Comerciales S.A.
IRCP
$5K ﹤0.01%
1,625
-1,802
-53% -$4.67K
AMED
1105
DELISTED
Amedisys
AMED
$4K ﹤0.01%
26
-15
-37% -$3.12K
ASO icon
1106
Academy Sports + Outdoors
ASO
$3.07B
$4K ﹤0.01%
+88
New +$3.51K
BVS icon
1107
Bioventus
BVS
$1.16B
$4K ﹤0.01%
290
-169
-37% -$2.6K
DBVT
1108
DBV Technologies
DBVT
$885M
$4K ﹤0.01%
83
-40
-33% -$2.07K
DNLI icon
1109
Denali Therapeutics
DNLI
$3.95B
$4K ﹤0.01%
70
-267
-79% -$15K
IMMR icon
1110
Immersion
IMMR
$248M
$4K ﹤0.01%
610
-1,572
-72% -$11.7K
LCID icon
1111
Lucid Motors
LCID
$2.64B
$4K ﹤0.01%
17
+7
+70% +$1.62K
LFST icon
1112
Lifestance Health
LFST
$4.39B
$4K ﹤0.01%
+246
New +$4.74K
LIQT icon
1113
LiqTech
LIQT
$23.1M
$4K ﹤0.01%
85
-129
-60% -$6.05K
NBIX icon
1114
Neurocrine Biosciences
NBIX
$16.5B
$4K ﹤0.01%
39
-18
-32% -$1.7K
NWS icon
1115
News Corp Class B
NWS
$17.7B
$4K ﹤0.01%
162
+56
+53% +$1.28K
TIL icon
1116
Instil Bio
TIL
$50.8M
$4K ﹤0.01%
11
-5
-31% -$1.87K
TKNO icon
1117
Alpha Teknova
TKNO
$378M
$4K ﹤0.01%
+141
New +$3.02K
VIPS icon
1118
Vipshop
VIPS
$7.2B
$4K ﹤0.01%
402
+15
+4% +$236
VSTM icon
1119
Verastem
VSTM
$638M
$4K ﹤0.01%
102
-17
-14% -$625
CTV
1120
DELISTED
Innovid Corp.
CTV
$4K ﹤0.01%
+378
New +$3.73K
FATH
1121
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$4K ﹤0.01%
+19
New +$3.74K
LGV
1122
DELISTED
Longview Acquisition Corp. II
LGV
$4K ﹤0.01%
+378
New +$3.73K
ZY
1123
DELISTED
Zymergen Inc. Common Stock
ZY
$4K ﹤0.01%
+297
New +$6.3K
FMTX
1124
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$4K ﹤0.01%
172
-107
-38% -$2.53K
HZNP
1125
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4K ﹤0.01%
35
-16
-31% -$1.66K

Similar funds

State of Wyoming's Q3 2021 Portfolio in Review

As of Q3 2021, State of Wyoming held 1,392 positions worth $156M, down 2% from $159M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

State of Wyoming's Q3 2021 filing shows 197 new, 444 increased, 602 reduced and 144 closed positions. Its largest new stake was SPDR Gold Trust: 6,621 shares worth $1.09M. The largest sale was Microsoft, an estimated $1.28M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • State of Wyoming's largest Q3 2021 buy was SPDR Gold Trust: 6,621 shares worth $1.09M.
  • State of Wyoming added most to Apple in Q3 2021, an estimated $1.6M increase.
  • State of Wyoming's biggest Q3 2021 reduction was Microsoft, cutting an estimated $1.28M.
  • State of Wyoming fully exited Invesco S&P 500 Equal Weight ETF in Q3 2021, selling an estimated $658K.
  • State of Wyoming's ten largest holdings make up 19% of its $156M portfolio in Q3 2021.
  • State of Wyoming opened 197 new positions and closed 144 in Q3 2021.
  • State of Wyoming's portfolio value fell 2% quarter-over-quarter to $156M.

Based on State of Wyoming's 13F filing for Q3 2021, filed 11 Feb 2022.